Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DVAX | Common Stock | Award | $8.48K | +2.5K | +2.33% | $3.39 | 110K | Aug 13, 2021 | Direct | F1 |
transaction | DVAX | Common Stock | Options Exercise | $18.8K | +4.17K | +3.79% | $4.50 | 114K | Aug 23, 2021 | Direct | |
transaction | DVAX | Common Stock | Sale | -$140K | -10K | -8.77% | $14.00 | 104K | Aug 24, 2021 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DVAX | Warrant (Right to Buy) | Options Exercise | -4.17K | -100% | 0 | Aug 23, 2021 | Common Stock | 4.17K | $4.50 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021 |
F2 | The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021. |
F3 | All shares were sold at $14.00 |
F4 | Warrants were issued in connection with a financing transaction dated August 12, 2019 and were immediately exercisable upon issuance and have an expiration date of February 12, 2022. |
F5 | Not applicable |